TED D CHUNG

Allopathic & Osteopathic Physicians|Urology DESTIN, FL NPI 1639148166

General Payments — all program years on this page

$5,759.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 232
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $373.17 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $373.1720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $262.4227
2019 $1,467.6628
2020 $388.6822
2021 $708.5130
2022 $1,254.5459
2023 $1,304.6546
2024 $373.1720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1138701627 Tolmar, Inc. $22.71 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139267372 Astellas Pharma US Inc $17.83 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139285336 Astellas Pharma US Inc $3.56 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139290414 Astellas Pharma US Inc $17.01 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139297716 Astellas Pharma US Inc $8.49 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139303576 Astellas Pharma US Inc $5.27 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139303826 Astellas Pharma US Inc $4.45 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139339836 Astellas Pharma US Inc $6.27 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139376526 Astellas Pharma US Inc $43.29 05/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139403369 Astellas Pharma US Inc $18.97 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139433348 Astellas Pharma US Inc $19.43 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141548434 Hollister Incorporated $21.48 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144027005 PROCEPT BioRobotics Corporation $32.38 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144027007 PROCEPT BioRobotics Corporation $44.60 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144937506 ABC Home Medical Supply, Inc. $21.48 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148838571 Sumitomo Pharma America, Inc. $14.21 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148838573 Sumitomo Pharma America, Inc. $13.71 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148838575 Sumitomo Pharma America, Inc. $23.73 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148838577 Sumitomo Pharma America, Inc. $20.53 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148838579 Sumitomo Pharma America, Inc. $13.77 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.